Title : Bexarotene gel: a new skin-directed treatment option for cutaneous T-cell lymphomas.

Pub. Date : 2003 Apr

PMID : 12852367






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In clinical trials, bexarotene gel demonstrated efficacy for the topical treatment of cutaneous lesions in patients with stage IA or IB CTCL who have refractory or persistent disease following other therapies or who cannot tolerate other therapies. Bexarotene TSPY like 2 Homo sapiens
2 The availability of bexarotene gel provides patients and physicians with a new skin-directed treatment option for early stage CTCL. Bexarotene TSPY like 2 Homo sapiens